1. Home
  2. PTCT vs DLO Comparison

PTCT vs DLO Comparison

Compare PTCT & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • DLO
  • Stock Information
  • Founded
  • PTCT 1998
  • DLO 2013
  • Country
  • PTCT United States
  • DLO Uruguay
  • Employees
  • PTCT N/A
  • DLO N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • DLO Business Services
  • Sector
  • PTCT Health Care
  • DLO Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • DLO Nasdaq
  • Market Cap
  • PTCT 5.3B
  • DLO 4.6B
  • IPO Year
  • PTCT 2013
  • DLO 2021
  • Fundamental
  • Price
  • PTCT $68.31
  • DLO $14.65
  • Analyst Decision
  • PTCT Buy
  • DLO Buy
  • Analyst Count
  • PTCT 15
  • DLO 9
  • Target Price
  • PTCT $67.67
  • DLO $15.00
  • AVG Volume (30 Days)
  • PTCT 949.1K
  • DLO 2.4M
  • Earning Date
  • PTCT 11-04-2025
  • DLO 11-12-2025
  • Dividend Yield
  • PTCT N/A
  • DLO 3.49%
  • EPS Growth
  • PTCT N/A
  • DLO 9.30
  • EPS
  • PTCT 7.72
  • DLO 0.48
  • Revenue
  • PTCT $1,764,929,000.00
  • DLO $863,482,000.00
  • Revenue This Year
  • PTCT $119.02
  • DLO $38.48
  • Revenue Next Year
  • PTCT N/A
  • DLO $26.72
  • P/E Ratio
  • PTCT $8.85
  • DLO $30.54
  • Revenue Growth
  • PTCT 96.00
  • DLO 22.02
  • 52 Week Low
  • PTCT $35.95
  • DLO $7.61
  • 52 Week High
  • PTCT $69.88
  • DLO $16.78
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 64.81
  • DLO 47.68
  • Support Level
  • PTCT $66.00
  • DLO $14.84
  • Resistance Level
  • PTCT $69.88
  • DLO $15.88
  • Average True Range (ATR)
  • PTCT 2.24
  • DLO 0.77
  • MACD
  • PTCT -0.30
  • DLO -0.08
  • Stochastic Oscillator
  • PTCT 71.61
  • DLO 10.88

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.

Share on Social Networks: